We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




World’s First Urine-Based HPV Test to Transform Cervical Cancer Screening

By LabMedica International staff writers
Posted on 16 Jun 2025

Human papillomavirus (HPV) is a very common sexually transmitted infection (STI) that causes more than 95% of cervical cancer cases. More...

Detection of HPV infections that lead to cellular transformation, followed by timely treatment, can lower the risk of developing cervical cancer.HPV testing is the most cost-effective technique for cervical screening. However, traditional cervical cancer screening methods can be invasive, uncomfortable, and require clinical visits, creating barriers to regular testing. Now, the world’s first urine-based HPV test that empowers convenient sample collection could potentially transform cervical cancer screening by making it more accessible and comfortable.

PHASE Scientific (Hong Kong) has developed the world’s first urine-based HPV test—a major breakthrough that has achieved significant clinical validation and global recognition. The company’s INDICAID HPV Urine Test can detect 14 types of high-risk HPV in urine samples, helping users identify cancer risks earlier and seek appropriate treatment options sooner.​ The test is based on the company’s proprietary urine concentration technology designed for molecular diagnostics that is setting a new industry benchmark by capturing approximately 10 times more target analytes from urine specimens compared to the current gold standard. The innovative PHASIFY technology enables the concentration and purification of unlimited volumes of urine, dramatically increasing the sensitivity and accuracy of disease detection.

PHASIFY technology enables at-home sample collection through urine, potentially increasing screening rates and earlier detection of HPV infections that could lead to cervical cancer. In a recent clinical study, the INDICAID HPV Urine Test demonstrated 93.4% sensitivity in detecting CIN2+ lesions (cervical precancer and cancer) and over 97% concordance with the gold-standard physician-collected testing for HPV types 16 and 18. Beyond HPV testing, the company is also developing a comprehensive suite of non-invasive tests for early detection of cancers, women’s health conditions, and infectious diseases based on its urine concentration platform.

Related Links:
PHASE Scientific


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more

Pathology

view channel
Image: A tool uses artificial intelligence and high-resolution imaging to track senescent cells (Courtesy of Adobe Stock)

AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease

Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.